Pancratistatin
CAS: 96203-70-2
Ref. 3D-WDA20370
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Informação sobre produto
- (+)-Pancratistatin
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-Hexahydro-1,2,3,4,7-pentahydroxy[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
- NSC 349156
- Pancratistatine
- [1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, [1R-(1α,2β,3α,4α,4aα,11bβ)]-
- [1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R,2S,3S,4S,4aR,11bR)-
- [1,3]dioxolo[4,5-j]phenanthridine-1,2,3,4,6,7-hexol, 1,2,3,4,4a,11b-hexahydro-, (1R,2S,3S,4S,4aR,11bR)-
Pancratistatin is a naturally occurring compound with potent medicinal properties. It has been shown to induce apoptosis, or programmed cell death, in a variety of cancer cell lines, making it a promising candidate for the development of anticancer therapies. Pancratistatin works by inhibiting kinases and other proteins that are involved in tumor growth and survival. It has been found to be effective against leukemia cells and has also shown promise as an inhibitor of Chinese hamster ovary cells. Additionally, pancratistatin can be isolated from urine samples, making it a potentially valuable diagnostic tool for detecting cancer. With its powerful anticancer properties, pancratistatin represents a promising avenue for the development of new cancer treatments.
Propriedades químicas
Consulta técnica sobre: 3D-WDA20370 Pancratistatin
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.